RESUMEN
Due to the emergence and rapid spread of drug resistance in bacteria, there is an urgent need for the development of novel antimicrobials. SecA, a key component of the general bacterial secretion system required for viability and virulence, is an attractive antimicrobial target. Earlier we reported that systematical dissection of a SecA inhibitor, Rose Bengal (RB), led to the development of novel small molecule SecA inhibitors active against Escherichia coli and Bacillus subtilis. In this study, two potent RB analogs were further evaluated for activities against methicillin-resistant Staphylococcus aureus (MRSA) strains and for their mechanism of actions. These analogs showed inhibition on the ATPase activities of S. aureus SecA1 (SaSecA1) and SecA2 (SaSecA2), and inhibition of SaSecA1-dependent protein-conducting channel. Moreover, these inhibitors reduce the secretion of three toxins from S. aureus and exert potent bacteriostatic effects against three MRSA strains. Our best inhibitor SCA-50 showed potent concentration-dependent bactericidal activity against MRSA Mu50 strain and very importantly, 2-60 fold more potent inhibitory effect on MRSA Mu50 than all the commonly used antibiotics including vancomycin, which is considered the last resort option in treating MRSA-related infections. Protein pull down experiments further confirmed SaSecA1 as a target. Deletion or overexpression of NorA and MepA efflux pumps had minimal effect on the antimicrobial activities against S. aureus, indicating that the effects of SecA inhibitors were not affected by the presence of these efflux pumps. Our studies show that these small molecule analogs target SecA functions, have potent antimicrobial activities, reduce the secretion of toxins, and have the ability to overcome the effect efflux pumps, which are responsible for multi-drug resistance. Thus, targeting SecA is an attractive antimicrobial strategy against MRSA.
Asunto(s)
Adenosina Trifosfatasas/antagonistas & inhibidores , Antiinfecciosos/química , Proteínas Bacterianas/antagonistas & inhibidores , Staphylococcus aureus Resistente a Meticilina/enzimología , Rosa Bengala/química , Adenosina Trifosfatasas/metabolismo , Antibacterianos/química , Antibacterianos/farmacología , Antiinfecciosos/farmacología , Proteínas Bacterianas/metabolismo , Sitios de Unión , Evaluación Preclínica de Medicamentos , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Cinética , Luz , Proteínas de Transporte de Membrana/metabolismo , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Simulación del Acoplamiento Molecular , Oxidación-Reducción , Estructura Terciaria de Proteína , Rosa Bengala/farmacología , Canales de Translocación SEC , Proteína SecA , Staphylococcus aureus/efectos de los fármacosRESUMEN
SecA is a central component of the general secretion system that is essential for bacterial growth and thus an ideal target for antimicrobial agents. A series of fluorescein analogues were first screened against the ATPase activity using the truncated unregulated SecA catalytic domain. Rose bengal (RB) and erythrosin B (EB) were found to be potent inhibitors SecA with IC(50) values of 0.5 µM and 2 µM, respectively. RB and EB inhibit the catalytic SecA ATPase more effectively than the F(1) F(0) -proton ATPase. We used three assays to test the effect of these compounds on full-length SecA ATPase: in solution (intrinsic ATPase), in membrane preparation, and translocation ATPase. RB and EB show the following trend in terms of IC(50) values: translocation ATPaseAsunto(s)
Adenosina Trifosfatasas/antagonistas & inhibidores
, Proteínas Bacterianas/antagonistas & inhibidores
, Inhibidores Enzimáticos/química
, Inhibidores Enzimáticos/farmacología
, Eritrosina/farmacología
, Fluoresceína/química
, Rosa Bengala/farmacología
, Antibacterianos/química
, Antibacterianos/farmacología
, Bacillus subtilis/efectos de los fármacos
, Bacillus subtilis/enzimología
, Proteínas de la Membrana Bacteriana Externa/metabolismo
, Evaluación Preclínica de Medicamentos/métodos
, Eritrosina/química
, Escherichia coli/efectos de los fármacos
, Escherichia coli/genética
, Concentración 50 Inhibidora
, Proteínas de Transporte de Membrana
, Modelos Moleculares
, Transporte de Proteínas/efectos de los fármacos
, Rosa Bengala/química
, Canales de Translocación SEC
, Proteína SecA
RESUMEN
SecA ATPase is a critical member of the Sec family, which is important in the translocation of membrane and secreted polypeptides/proteins in bacteria. Small molecule inhibitors can be very useful research tools as well as leads for future antimicrobial agent development. Based on previous virtual screening work, we optimized the structures of two hit compounds and obtained SecA ATPase inhibitors with IC(50) in the single digit micromolar range. These represent the first low micromolar synthetic inhibitors of bacterial SecA and will be very useful for mechanistic studies.